These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 20212482)

  • 21. OTA panel opens inquiry into patenting of genes.
    Macilwain C
    Nature; 1993 Apr; 362(6419):386. PubMed ID: 8464461
    [No Abstract]   [Full Text] [Related]  

  • 22. Napster case spills into biotech sector.
    Bouchie A
    Nat Biotechnol; 2004 Sep; 22(9):1185-6. PubMed ID: 15384189
    [No Abstract]   [Full Text] [Related]  

  • 23. Patenting pluripotence: the next battle for stem cell intellectual property.
    Vrtovec KT; Scott CT
    Nat Biotechnol; 2008 Apr; 26(4):393-5. PubMed ID: 18392018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In search of a compromised solution to the problem arising from patenting biomedical research tools.
    Derzko NM
    Santa Clara Comput High Technol Law J; 2004; 20(2):347-410. PubMed ID: 16493840
    [No Abstract]   [Full Text] [Related]  

  • 25. Recent US patent legislation: what's new for biotech?
    Gogoris AC; Todaro JC
    Nat Biotechnol; 2000 Feb; 18(2):229-31. PubMed ID: 10657135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patenting race.
    Kahn J
    Nat Biotechnol; 2006 Nov; 24(11):1349-51. PubMed ID: 17093476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patenting biotechnology inventions in China.
    Lui J
    Nat Biotechnol; 2001 Jan; 19(1):83-4. PubMed ID: 11135559
    [No Abstract]   [Full Text] [Related]  

  • 28. The gene patenting controversy: a convergence of law, economic interests, and ethics.
    Kevles DJ; Berkowitz A
    Brooklyn Law Rev; 2001; 67(1):233-48. PubMed ID: 12645549
    [No Abstract]   [Full Text] [Related]  

  • 29. Patenting human life and the rebirth of the Thirteenth Amendment.
    McDonald ES
    Notre Dame Law Rev; 2003 May; 78(4):1359-87. PubMed ID: 15237536
    [No Abstract]   [Full Text] [Related]  

  • 30. Biotech Patenting--EuroLegal Conference. 26-27 February 2003, London, UK.
    Pereira N
    IDrugs; 2003 Apr; 6(4):340-4. PubMed ID: 12839015
    [No Abstract]   [Full Text] [Related]  

  • 31. EU states back biotech patent reforms.
    Dickson D; Butler D
    Nature; 1993 Dec 23-30; 366(6457):713. PubMed ID: 8264788
    [No Abstract]   [Full Text] [Related]  

  • 32. Biotech patents: the world is your oyster--or mouse--or (you name it).
    Alix JE
    Technol Health Care; 1996 Sep; 4(3):255-8. PubMed ID: 8931235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Equivalents in biotechnology patents.
    Auer HE
    Nat Biotechnol; 2003 Mar; 21(3):329-31. PubMed ID: 12610574
    [No Abstract]   [Full Text] [Related]  

  • 34. "Ganske" threatens biotechnology patents worldwide.
    Glaser V
    Nat Biotechnol; 1997 Feb; 15(2):121. PubMed ID: 9035128
    [No Abstract]   [Full Text] [Related]  

  • 35. Lords panel backs ethical barriers to biotech patents.
    Nature; 1994 Mar; 368(6469):278. PubMed ID: 8127355
    [No Abstract]   [Full Text] [Related]  

  • 36. Ethical aspects of patenting human genotypes according to EC Biotechnology Directive.
    Spranger TM
    IIC Int Rev Ind Prop Copyr Law; 2000 Jun; 31(4):373-80. PubMed ID: 12956125
    [No Abstract]   [Full Text] [Related]  

  • 37. US acts to lengthen term of patents to help biotechnology.
    Wadman M
    Nature; 1999 Aug; 400(6745):604. PubMed ID: 10458149
    [No Abstract]   [Full Text] [Related]  

  • 38. Patents, biotechnology, and hematologic pathology.
    Kettelberger DM; Gambrell P; McClung G
    Hematol Pathol; 1992; 6(2):99-104. PubMed ID: 1607346
    [No Abstract]   [Full Text] [Related]  

  • 39. Patenting Dr. Venter's genetic findings: is the National Institutes of Health creating hurdles or clearing the path for biotechnology's voyage in the twenty-first century?
    Riley PJ
    J Contemp Health Law Policy; 1994; 10():309-26. PubMed ID: 10134812
    [No Abstract]   [Full Text] [Related]  

  • 40. Beyond the letter of the law: the US Federal Circuit interprets section 271(g)(1).
    Tsao R; Hurley EA
    Nat Biotechnol; 1997 Jan; 15(1):86-7. PubMed ID: 9035112
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.